The impact of a vaginal brachytherapy boost to pelvic radiation in stage III endometrial cancer

Journal of Contemporary Brachytherapy

Volumn 7, Issue 2, 2015, Pages 122-127

  Huddleston, Adam ^a   Zhen, Sally ^a   Qi, Lihong ^a   Rash, Dominique ^a   Leiserowitz, Gary ^b   Mayadev, Jyoti ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Endometrial cancer; Pelvic radiation therapy; Vaginal brachytherapy

Indexed keywords

CARBOPLATIN; CISPLATIN; IRIDIUM 192; PACLITAXEL;

ABDOMINAL HYSTERECTOMY; ABDOMINAL RADIOTHERAPY; ARTICLE; BLACK PERSON; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CAUCASIAN; CERVICAL STROMAL INVOLVEMENT; COMORBIDITY; COMPUTER ASSISTED RADIOTHERAPY; DISTANT METASTASIS; DRUG MEGADOSE; ENDOMETRIUM CARCINOMA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HISPANIC; HUMAN; INTENSITY MODULATED RADIATION THERAPY; KARNOFSKY PERFORMANCE STATUS; LYMPH VESSEL METASTASIS; LYMPHOVASCULAR SPACE INVASION; MAJOR CLINICAL STUDY; MEASUREMENT ACCURACY; MULTIPLE CYCLE TREATMENT; MYOMETRIAL INVASION; OUTCOME ASSESSMENT; PELVIC RADIOTHERAPY; PELVIS LYMPH NODE; QUALITY CONTROL; RADIATION DOSE FRACTIONATION; RADIOISOTOPE THERAPY; SALPINGOOOPHORECTOMY; SYSTEMIC THERAPY; TREATMENT FAILURE; TUMOR INVASION; UTERUS SURGERY; VAGINAL BRACHYTHERAPY BOOST; VAGINAL INVOLVEMENT;

EID: 84929319799     PISSN: 1689832X     EISSN: None     Source Type: Journal    
DOI: 10.5114/jcb.2015.50877     Document Type: Article

References (12)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29.
2. Hogberg T, Signorelli M, de Oliveira CF et al. Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer - results from two randomised studies. Eur J Cancer 2010; 46: 2422-2431.
3. Lee LJ, Viswanathan AN. Combined chemotherapy and radiation improves survival for node-positive endometrial cancer. Gynecol Oncol 2012; 127: 32-37.
4. Nelson G, Randall M, Sutton G et al. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy. Gynecol Oncol 1999; 75: 211-214.
5. Schorge JO, Molpus KL, Goodman A et al. The effect of post-surgical therapy on stage III endometrial carcinoma. Gynecol Oncol 1996; 63: 34-39.
6. Secord AA, Geller MA, Broadwater G et al. A multicenter evaluation of adjuvant therapy in women with optimally resected stage IIIC endometrial cancer. Gynecol Oncol 2013; 128: 65-70.
7. Randall ME, Spirtos NM, Dvoretsky P. Whole abdominal radiotherapy versus combination chemotherapy with doxorubicin and cisplatin in advanced endometrial carcinoma (phase III): Gynecologic Oncology Group Study No. 122. J Natl Cancer Inst Monogr 1995; 19: 13-15.
8. Klopp AH, Jhingran A, Ramondetta L et al. Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation. Gynecol Oncol 2009; 115: 6-11.
9. Mundt AJ, McBride R, Rotmensch J et al. Significant pelvic recurrence in high-risk pathologic stage I-IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 2001; 50: 1145-1153.
10. Mundt AJ, Murphy KT, Rotmensch J et al. Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma. Int J Radiat Oncol Biol Phys 2001; 50: 1154-1160.
11. Rossi PJ, Jani AB, Horowitz IR et al. Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis. Int J Radiat Oncol Biol Phys 2008; 70: 134-138.
12. Greven K, Winter K, Underhill K et al. Final analysis of RTOG 9708: Adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer. Gynecol Oncol 2006; 103: 155-159.